Cross-sectional study finds no significant link between blood groups, haemoglobin phenotypes, and fasting glucose in pregnant women, indicating blood traits do not drive gestational glycemia.
Background: This study examined the relationship between ABO, Rhesus D blood groups and haemoglobin phenotypes with fasting capillary blood glucose level in pregnant women in Owerri, Nigeria. Method: The method used was the analytical cross sectional study with 84 pregnant women as subjects. Capillary glucose level was determined by a glucose meter, ABO blood group and Rhesus D typing by agglutination and haemoglobin phenotypes by electrophoresis. Descriptive statistics and one-way analysis of variance at p < 0.05 were used to analyse the data. Method: The method used was the analytical cross sectional study with 84 pregnant women as subjects. Capillary glucose level was determined by a glucose meter, ABO blood group and Rhesus D typing by agglutination and haemoglobin phenotypes by electrophoresis. Descriptive statistics and one-way analysis of variance at p < 0.05 were used to analyse the data. Results: The age group 25-29 years old comprised most participants (32.1%) and 48.8% were in their third trimester. 13.1% reported having a previous history of gestational diabetes and 34.5% had a family history of diabetes. HbAA predominated (71.4%), followed by HbAS (26.2%) and HbAC (2.4%). The most common blood group was O positive (61.9%) and 95.2% were Rhesus D positive. Mean fasting glucose was 172.20 ± 23.60 mg/dL, with a median of 165.50 mg/dL and range of 140–248 mg/dL. The level of all participants was ≥126 mg/dL. There was no significant difference between ABO/Rhesus D groups (F = 1.132, p = 0.348) or haemoglobin phenotypes (F = 1.786, p = 0.174) with regard to the fasting glucose. Conclusion: The predominant ones were HbAA, O positive and Rhesus D positive. There was no significant association between ABO/Rhesus D blood group and haemoglobin phenotype with fasting capillary glucose. The consistently high results should be confirmed by standard laboratory methods.
No takes yet. Share an insight, caveat, or question.
Chinedu Barry Iheukwumere1, Melford Uche Elendu2, Chigaemezu RemmyMartin Akubuo3*, Chinedu Dominic Ejiofor4, Ebere Otuomasirichi Ibezim5, Kelechi Levi Okereke6, Ernest Emeka Ngwu7 and Ezechukwu Gift Akandu8 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: